Biotech Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity’s 44th Annual Growth Conference August 8, 2024
Biotech Diabetes Supplements Market to Reach USD 13.4 billion by 2031, Growth at CAGR 4.2% | Report by Transparency Market Research, Inc. August 6, 2024
Featured News Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder and Alzheimer’s Disease August 6, 2024
Biotech Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder August 6, 2024
Biotech Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine August 5, 2024
Biotech Invitation to the presentation of Calliditas´s interim report January – June 2024 August 5, 2024
Biotech Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery August 5, 2024